EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Naphthalimide–organometallic hybrids as multi-targeted anticancer and luminescent cellular imaging agents

David C Magri iD, Alex D Johnson iD

RSC Medicinal Chemistry · 2025 · 16 (10) · 4657-4675

DOI: 10.1039/d5md00205b ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift RSC Medicinal Chemistry, 2025. Verfasst von David C Magri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, University of Malta Msida MSD 2080 Malta david.magri@um.edu.mt +(356) 2340 2276. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Università ta' Malta.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Naphthalimide–organometallic hybrids are reviewed as intelligent agents for antineoplastic and luminescence sensing applications.

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, University of Malta Msida MSD 2080 Malta david.magri@um.edu.mt +(356) 2340 2276.

ORCID-Profile: David C Magri, Alex D Johnson

Förderung

  • Università ta' Malta

Zitieren

APA

Magri, D. C., & Johnson, A. D. (2025). Naphthalimide–organometallic hybrids as multi-targeted anticancer and luminescent cellular imaging agents. RSC Medicinal Chemistry, 16(10), 4657-4675. https://doi.org/10.1039/d5md00205b

Vancouver

Magri DC, Johnson AD. Naphthalimide–organometallic hybrids as multi-targeted anticancer and luminescent cellular imaging agents. RSC Medicinal Chemistry. 2025;16(10):4657-4675. doi:10.1039/d5md00205b

BibTeX
@article{Magri2025,
  author = {Magri, David C and Johnson, Alex D},
  title = {Naphthalimide–organometallic hybrids as multi-targeted anticancer and luminescent cellular imaging agents},
  journal = {RSC Medicinal Chemistry},
  year = {2025},
  volume = {16},
  number = {10},
  pages = {4657--4675},
  doi = {10.1039/d5md00205b}
}
Kostenlos starten →